1
|
Byabagambi JB, Hollingsworth B, Limmer M. Deficits and opportunities, pivots and shifts for scaling-up voluntary medical male circumcision in Uganda: a qualitative reflexive thematic analysis study. BMC Public Health 2024; 24:2232. [PMID: 39152417 PMCID: PMC11329999 DOI: 10.1186/s12889-024-19796-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2023] [Accepted: 08/14/2024] [Indexed: 08/19/2024] Open
Abstract
Despite voluntary medical male circumcision (VMMC) being a cost-effective intervention for preventing HIV transmission, its scale-up has faced challenges. Several interventions to address these challenges in priority countries, including Uganda, have not yielded the desired results. This cross-sectional qualitative study aimed to explore the factors that affect the demand for VMMC and identify possible solutions. Semi-structured phone interviews were conducted with 29 males aged at least 18 and not more than 65 drawn randomly from a database representative of the general population maintained by an independent research organisation. Reflexive thematic analysis was conducted, and data analysis was done using NVivo version 12. The results were presented in narrative format with supporting quotes. The study received ethical and regulatory clearance to be conducted in Uganda. The average age of the respondents was 28 years. Almost all respondents had some education, and most lived in rural areas. Two themes were generated, namely, 1) deficits and opportunities for VMMC, which are issues that currently hinder the uptake of VMMC but, if addressed, would lead to better demand, and 2) pivots and shifts for VMMC, which are changes that need to be made to improve the uptake of VMMC. We found that several challenges, including myths, misconceptions, health system gaps, and uncertainties about the postoperative period, hindered the uptake of VMMC. Pivots and shifts for improving the uptake of VMMC include intensifying VMMC campaigns, addressing inequities, and addressing access barriers. We concluded that several challenges, including myths and misconceptions, health system-related gaps, and uncertainties in the post-circumcision period, persist and negatively impact the scale-up of VMMC in Uganda. VMMC beneficiaries have plausible proposals for addressing challenges. The Uganda Ministry of Health should address the myths, misconceptions, health system-related gaps, and uncertainties about the postoperative period and should involve VMMC beneficiaries in reviewing interventions to address gaps.
Collapse
Affiliation(s)
| | | | - Mark Limmer
- Department of Health Research, Lancaster University, Lancaster, UK
| |
Collapse
|
2
|
Gao Y, Zhan Y, Sun Y, Zheng W, Zhang W, Fu L, Guo Z, Lin YF, Li Y, Zheng L, Zhan Y, Zhu Z, Duan J, Zhang G, Huang T, Su B, Yu M, Wu G, Ouyang L, Zhao J, Wang G, Zhou Y, Qian HZ, Fitzpatrick T, Vermund SH, Zou H. Efficacy of Voluntary Medical Male Circumcision to Prevent HIV Infection Among Men Who Have Sex With Men : A Randomized Controlled Trial. Ann Intern Med 2024; 177:719-728. [PMID: 38801778 DOI: 10.7326/m23-3317] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/29/2024] Open
Abstract
BACKGROUND Observational studies suggest that voluntary medical male circumcision (VMMC) may lower HIV risk among men who have sex with men (MSM). A randomized controlled trial (RCT) is needed to confirm this. OBJECTIVE To assess the efficacy of VMMC in preventing incident HIV infection among MSM. DESIGN An RCT with up to 12 months of follow-up. (Chinese Clinical Trial Registry: ChiCTR2000039436). SETTING 8 cities in China. PARTICIPANTS Uncircumcised, HIV-seronegative men aged 18 to 49 years who self-reported predominantly practicing insertive anal intercourse and had 2 or more male sex partners in the past 6 months. INTERVENTION VMMC. MEASUREMENTS Rapid testing for HIV was done at baseline and at 3, 6, 9, and 12 months. Behavioral questionnaires and other tests for sexually transmitted infections were done at baseline, 6 months, and 12 months. The primary outcome was HIV seroconversion using an intention-to-treat analysis. RESULTS The study enrolled 124 men in the intervention group and 123 in the control group, who contributed 120.7 and 123.1 person-years of observation, respectively. There were 0 seroconversions in the intervention group (0 infections [95% CI, 0.0 to 3.1 infections] per 100 person-years) and 5 seroconversions in the control group (4.1 infections [CI, 1.3 to 9.5 infections] per 100 person-years). The HIV hazard ratio was 0.09 (CI, 0.00 to 0.81; P = 0.029), and the HIV incidence was lower in the intervention group (log-rank P = 0.025). The incidence rates of syphilis, herpes simplex virus type 2, and penile human papillomavirus were not statistically significantly different between the 2 groups. There was no evidence of HIV risk compensation. LIMITATION Few HIV seroconversions and limited follow-up period. CONCLUSION Among MSM who predominantly practice insertive anal intercourse, VMMC is efficacious in preventing incident HIV infection; MSM should be included in VMMC guidelines. PRIMARY FUNDING SOURCE The National Science and Technology Major Project of China.
Collapse
Affiliation(s)
- Yanxiao Gao
- Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, and School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China (Y.G.)
| | - Yuewei Zhan
- Discipline Development Office, Shenzhen People's Hospital, Shenzhen, China (YueweiZhan)
| | - Yinghui Sun
- The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China (Y.S.)
| | - Weiran Zheng
- School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China (W.Zheng, W.Zhang, L.F., Z.G., Y.L., YiqiangZhan)
| | - Weijie Zhang
- School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China (W.Zheng, W.Zhang, L.F., Z.G., Y.L., YiqiangZhan)
| | - Leiwen Fu
- School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China (W.Zheng, W.Zhang, L.F., Z.G., Y.L., YiqiangZhan)
| | - Zhihui Guo
- School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China (W.Zheng, W.Zhang, L.F., Z.G., Y.L., YiqiangZhan)
| | - Yi-Fan Lin
- Department of Spine Surgery/Orthopaedics, the First Affiliated Hospital, Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, China (Y.-F.L.)
| | - Yuwei Li
- School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China (W.Zheng, W.Zhang, L.F., Z.G., Y.L., YiqiangZhan)
| | - Lingling Zheng
- Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China (L.Z.)
| | - Yiqiang Zhan
- School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China (W.Zheng, W.Zhang, L.F., Z.G., Y.L., YiqiangZhan)
| | - Zhiqiang Zhu
- Beijing Youan Hospital, Capital Medical University, Beijing, China (Z.Z., J.D., G.Z., T.H., B.S.)
| | - Junyi Duan
- Beijing Youan Hospital, Capital Medical University, Beijing, China (Z.Z., J.D., G.Z., T.H., B.S.)
| | - Guanghui Zhang
- Beijing Youan Hospital, Capital Medical University, Beijing, China (Z.Z., J.D., G.Z., T.H., B.S.)
| | - Tao Huang
- Beijing Youan Hospital, Capital Medical University, Beijing, China (Z.Z., J.D., G.Z., T.H., B.S.)
| | - Bin Su
- Beijing Youan Hospital, Capital Medical University, Beijing, China (Z.Z., J.D., G.Z., T.H., B.S.)
| | - Maohe Yu
- Tianjin Center for Disease Control and Prevention, Tianjin, China (M.Y.)
| | - Guohui Wu
- Chongqing Center for Disease Control and Prevention, Chongqing, China (G.Wu, L.O.)
| | - Lin Ouyang
- Chongqing Center for Disease Control and Prevention, Chongqing, China (G.Wu, L.O.)
| | - Jin Zhao
- Shenzhen Center for Disease Control and Prevention, Shenzhen, China (J.Z.)
| | - Guanghui Wang
- Qingdao Qingtong AIDS Prevention Volunteer Service Center, Qingdao, China (G.Wang)
| | - Yepeng Zhou
- Foshan Friend Care Center for AIDS/HIV Control, Foshan, China (Y.Zhou)
| | - Han-Zhu Qian
- Departments of Biostatistics and Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut (H.-Z.Q.)
| | - Thomas Fitzpatrick
- Department of Internal Medicine, University of Washington, Seattle, Washington (T.F.)
| | - Sten H Vermund
- Departments of Biostatistics and Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, and Global Virus Network, Baltimore, Maryland (S.H.V.)
| | - Huachun Zou
- School of Public Health, Fudan University, Shanghai, China, and Shenzhen Campus, Sun Yat-sen University, Shenzhen, China (H.Z.)
| |
Collapse
|
3
|
Stojanovski K, King EJ, O'Connell S, Gallagher KS, Theall KP, Geronimus AT. Spiraling Risk: Visualizing the multilevel factors that socially pattern HIV risk among gay, bisexual & other men who have sex with men using Complex Systems Theory. Curr HIV/AIDS Rep 2023; 20:206-217. [PMID: 37486568 PMCID: PMC10403445 DOI: 10.1007/s11904-023-00664-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/23/2023] [Indexed: 07/25/2023]
Abstract
PURPOSE OF REVIEW Global disparities in HIV infection, particularly among gay, bisexual, and other men who have sex with men (GBMSM), indicate the importance of exploring the multi-level processes that shape HIV's spread. We used Complex Systems Theory and the PRISMA guidelines to conduct a systematic review of 63 global reviews to understand how HIV is socially patterned among GBMSM. The purpose was to conduct a thematic analysis of the reviews to (1) synthesize the multi-level risk factors of HIV risk, (2) categorize risk across the socioecological model, and (3) develop a conceptual model that visualizes the interrelated factors that shape GBMSMS's HIV "risk." RECENT FINDINGS We included 49 studies of high and moderate quality studies. Results indicated that GBMSM's HIV risk stems from the individual, interpersonal, and structural levels of the socioecological model. We identified a few themes that shape GBMSM's risk of HIV infection related to biomedical prevention methods; sexual and sex-seeking behaviors; behavioral prevention methods; individual-level characteristics and syndemic infections; lived experiences and interpersonal relationships; country-level income; country-level HIV prevalence; and structural stigma. The multi-level factors, in tandem, serve to perpetuate GBMSM's risk of HIV infection globally. The amalgamation of our thematic analyses from our systematic reviews of reviews suggests that the risk of HIV infection operates in an emergent, dynamic, and complex nature across multiple levels of the socioecological model. Applying complex systems theory indicates how multilevel factors create a dynamic and reinforcing system of HIV risk among GBMSM.
Collapse
Affiliation(s)
- K Stojanovski
- Department of Social, Behavioral and Population Sciences, Tulane School of Public Health & Tropical Medicine, New Orleans, USA.
| | - E J King
- Department of Health Behavior & Health Education, School of Public Health, University of Michigan, Ann Arbor, USA
| | - S O'Connell
- Department of Epidemiology, Tulane School of Public Health & Tropical Medicine, New Orleans, USA
| | - K S Gallagher
- Department of Health Policy and Management, Tulane School of Public Health & Tropical Medicine, New Orleans, USA
| | - K P Theall
- Department of Social, Behavioral and Population Sciences, Tulane School of Public Health & Tropical Medicine, New Orleans, USA
- Department of Epidemiology, Tulane School of Public Health & Tropical Medicine, New Orleans, USA
| | - A T Geronimus
- Department of Health Behavior & Health Education, School of Public Health, University of Michigan, Ann Arbor, USA
- Institute for Social Research, University of Michigan, Ann Arbor, USA
| |
Collapse
|
4
|
Gao Y, Zheng W, Sun Y, Yang L, Guo Z, Li Y, Lin YF, Lu Z, Yuan T, Zhan Y, Qian HZ, Su B, Zhu Z, Duan J, Wang G, Cui X, Ouyang L, Sheng G, Zhou Y, Long A, Yao Y, Fitzpatrick T, Yu M, Wu G, Zou H. Voluntary Medical Male Circumcision and Incident HIV Infection Among Men Who Have Sex With Men in China (The CoM Study): Protocol for a Randomized Controlled Trial. JMIR Res Protoc 2023; 12:e47160. [PMID: 37247211 PMCID: PMC10262017 DOI: 10.2196/47160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2023] [Revised: 04/30/2023] [Accepted: 05/05/2023] [Indexed: 05/30/2023] Open
Abstract
BACKGROUND Systematic reviews and meta-analyses based on observational studies have shown voluntary medical male circumcision (VMMC) may reduce HIV risk among men who have sex with men (MSM). There is a lack of randomized controlled trial (RCT) data assessing the efficacy of VMMC. OBJECTIVE The primary objective of this study was to assess the efficacy of VMMC for preventing HIV acquisition among MSM who primarily engage in insertive anal sex. METHODS A multicenter RCT will be conducted among MSM in 8 cities in China. Eligible participants are men aged 18-49 years who self-report ≥2 male sex partners in the past 6 months, predominantly practice insertive anal sex, and are willing to undergo circumcision. Interested men who satisfy inclusion criteria will be tested for HIV 1 month before enrollment and at enrollment, and only those who are HIV negative will be enrolled. At baseline, all enrolled participants will be asked to report sociodemographic characteristics and sexual behaviors; provide a blood sample for HIV, syphilis, and herpes simplex virus type 2 testing; and provide a penile swab for human papillomavirus testing. Participants will be randomly assigned to the intervention or control group. Those in the intervention group will receive VMMC and undergo a web-based weekly follow-up assessment of postsurgery healing for 6 consecutive weeks. All participants will be tested for HIV at 3-, 6-, 9-, and 12-month follow-ups. All participants will also be asked to report sexual behaviors and undergo repeat herpes simplex virus type 2 and human papillomavirus testing at 6- and 12-month follow-ups. The primary end point is HIV seroconversion. Secondary end points are the safety and satisfaction with VMMC and the changes in sexual behaviors after VMMC. The grouped censored data will be analyzed by intention-to-treat approach. RESULTS Recruitment for the RCT began in August 2020 and continued through July 2022. Data collection is expected to be completed by July 2023, and full data analysis is going to be completed by September 2023. CONCLUSIONS This study will be the first RCT to assess the efficacy of VMMC in preventing HIV infection among MSM. Results from this trial will provide preliminary evidence for the potential efficacy of VMMC to reduce incident HIV infection among MSM. TRIAL REGISTRATION Chinese Clinical Trial Registry ChiCTR2000039436; https://www.chictr.org.cn/showproj.html?proj=63369. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) DERR1-10.2196/47160.
Collapse
Affiliation(s)
- Yanxiao Gao
- School of Public Health, Sun Yat-sen University, Shenzhen, China
| | - Weiran Zheng
- School of Public Health, Sun Yat-sen University, Shenzhen, China
| | - Yinghui Sun
- School of Public Health, Sun Yat-sen University, Shenzhen, China
| | - Luoyao Yang
- School of Public Health, Sun Yat-sen University, Shenzhen, China
| | - Zhihui Guo
- School of Public Health, Sun Yat-sen University, Shenzhen, China
| | - Yuwei Li
- School of Public Health, Sun Yat-sen University, Shenzhen, China
| | - Yi-Fan Lin
- School of Public Health, Sun Yat-sen University, Shenzhen, China
| | - Zhen Lu
- School of Public Health, Sun Yat-sen University, Shenzhen, China
| | - Tanwei Yuan
- School of Public Health, Sun Yat-sen University, Shenzhen, China
| | - Yuewei Zhan
- School of Public Health, Sun Yat-sen University, Shenzhen, China
| | - Han-Zhu Qian
- GlaxoSmithKline plc, Rockville, MD, United States
| | - Bin Su
- Beijing Youan Hospital, Capital Medical University, Beijing, China
| | - Zhiqiang Zhu
- Beijing Youan Hospital, Capital Medical University, Beijing, China
| | - Junyi Duan
- Beijing Youan Hospital, Capital Medical University, Beijing, China
| | - Guanghui Wang
- Qingdao Qingtong AIDS Prevention Volunteer Service Center, Qingdao, China
| | - Xin Cui
- Qingdao Qingtong AIDS Prevention Volunteer Service Center, Qingdao, China
| | - Lin Ouyang
- Chongqing Municipal Center for Disease Control and Prevention, Chongqing, China
| | - Genshen Sheng
- Shenzhen Rainbow 258 Centre for Men, Shenzhen, China
| | - Yepeng Zhou
- Foshan Pengyou Care and Rescue Center for AIDS Prevention, Foshan, China
| | - Ao Long
- Luzhou Red Ribbon Heart Association, Luzhou, China
| | - Yuming Yao
- Zhitong LGBT Service Center, Guangzhou, China
| | - Thomas Fitzpatrick
- Department of Internal Medicine, University of Washington, Seattle, WA, United States
| | - Maohe Yu
- Tianjin Municipal Center for Disease Control and Prevention, Tianjin, China
| | - Guohui Wu
- Chongqing Municipal Center for Disease Control and Prevention, Chongqing, China
| | - Huachun Zou
- School of Public Health, Sun Yat-sen University, Shenzhen, China
- Kirby Institute, University of New South Wales, Sydney, Australia
| |
Collapse
|
5
|
Voluntary Medical Male Circumcision for HIV Prevention: a Global Overview. Curr HIV/AIDS Rep 2022; 19:474-483. [PMID: 36348186 DOI: 10.1007/s11904-022-00632-y] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/05/2022] [Indexed: 11/09/2022]
Abstract
PURPOSE OF REVIEW With the promise of HIV prevention, there has been a scale-up of voluntary medical male circumcision (VMMC) in high HIV incidence/low circumcision prevalence nations worldwide. Nonetheless, debates over the implementation and the effectiveness and safety of the VMMC in real-world settings persist. We revisit the role of VMMC in HIV prevention to inform health professionals, policymakers, and advocates or opponents in this new era. RECENT FINDINGS There has been substantial progress on VMMC scale-up to date, but this has varied considerably by region. The evidence of solid and direct protection of VMMC is available for heterosexual men and older adolescent boys in sub-Saharan Africa. The protective effect in men who have sex with men is suggested by systematic reviews but is not confirmed by clinical trials. Sexual partners, including women, likely benefit indirectly from the increased VMMC coverage through a decreased risk of exposure to infected male partners. Fortunately, the preponderance of studies does not suggest higher sexual risk behaviors among circumcised men, so-called risk compensation. VMMC requires health systems strengthening and continued promulgation of other evidence-based HIV prevention strategies to be successful. Health authorities in high HIV incidence areas that have low circumcision coverage should implement VMMC within a context of complementary biomedical and behavioral prevention strategies.
Collapse
|
6
|
Lin Y, Gao Y, Sun Y, Turner D, Zou H, Vermund SH, Qian HZ. Does Voluntary Medical Male Circumcision Reduce HIV Risk in Men Who Have Sex with Men? Curr HIV/AIDS Rep 2022; 19:522-525. [PMID: 36520379 DOI: 10.1007/s11904-022-00637-7] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/11/2022] [Indexed: 12/23/2022]
Abstract
PURPOSE OF REVIEW To review the evidence on the effect of voluntary medical male circumcision (VMMC) on reducing HIV risk among men who have sex with men (MSM) and assess the limitations of available evidence. RECENT FINDINGS Individual studies have shown conflicting results, but recent meta-analyses have consistently suggested that VMMC was associated with 7 to 23% reductions in HIV prevalence or incidence in MSM, particularly among a subgroup of men who predominantly practice insertive role in anal sex. Mathematical models have also suggested a moderate population-level impact of VMMC intervention. All original studies have been observational and are subject to confounding and bias. Randomized clinical trials (RCTs) are needed to provide strong evidence of assessing the efficacy of VMMC on HIV risk among MSM. VMMC is a promising HIV risk reduction tool for MSM. RCTs are needed to evaluate the efficacy of VMMC intervention.
Collapse
Affiliation(s)
- Yidie Lin
- West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China
| | - Yanxiao Gao
- School of Public Health (Shenzhen), Sun Yat-Sen University, Shenzhen, China
| | - Yue Sun
- West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China
| | - DeAnne Turner
- College of Nursing, University of South Florida, Tampa, FL, USA
| | - Huachun Zou
- School of Public Health (Shenzhen), Sun Yat-Sen University, Shenzhen, China
| | - Sten H Vermund
- School of Public Health, Yale University, Suite 501, 300 George Street, New Haven, CT, USA
| | - Han-Zhu Qian
- School of Public Health, Yale University, Suite 501, 300 George Street, New Haven, CT, USA.
- GlaxoSmithKline Plc, Rockville, MD, USA.
| |
Collapse
|
7
|
Zhang C, Webb GF, Lou J, Shepherd BE, Qian HZ, Liu Y, Vermund SH. Predicting the long-term impact of voluntary medical male circumcision on HIV incidence among men who have sex with men in Beijing, China. AIDS Care 2019; 32:343-353. [PMID: 31619058 DOI: 10.1080/09540121.2019.1679704] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
Using a deterministic compartmental modeling procedure to fit prevalence from 2005-2015, we projected new HIV cases during 2016-2026 under different coverage rates ranging from 0.0001 (at baseline) to 0.15 (an optimistic assumption) with simulations on varying transmission rates, model calibration to match historical data, and sensitivity analyses for different assumptions. Compared with the baseline (λ = 0.0001), we found the new HIV cases would reduce with the increase of coverage rates of the voluntary medical male circumcision (VMMC) among men who have sex wtih men (MSM). The higher the coverage rate, the lower the new HIV incidence would be. As one of the first studies to model the potential impact of VMMC among MSM in China, our model suggested a modest to the significant public health impact of VMMC. Even at just 15% VMMC annual uptake rate, the reduction in new infections is substantial. Therefore, there is a strong need to determine the efficacy of VMMC among MSM, to improve the evidence base for its potential use among MSM in low circumcision settings. Only then can policymakers decide whether to incorporate VMMC into a package of HIV prevention interventions targeting MSM.
Collapse
Affiliation(s)
- Chen Zhang
- School of Nursing, University of Rochester Medical Center, Rochester, NY, USA
| | - Glenn F Webb
- Departments of Mathematics, Vanderbilt University, Nashville, TN, USA
| | - Jie Lou
- Department of Mathematics, Shanghai University, Shanghai, People's Republic of China
| | - Brian E Shepherd
- Departments of Biostatistics, Vanderbilt University, Nashville, TN, USA
| | - Han-Zhu Qian
- School of Public Health, Yale University, New Haven, CT, USA
| | - Yu Liu
- Department of Public Health Science, University of Rochester Medical Center, Rochester, NY, USA
| | - Sten H Vermund
- School of Public Health, Yale University, New Haven, CT, USA
| |
Collapse
|